OR7A10

Across TCGA pan-cancer cohorts, OR7A10 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR7A10 data layer compared with 6 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher OR7A10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7A10 expression acts as an unfavorable survival marker, although some lineages such as ESCA and COAD show a favorable association.

KICH, PAAD, and GBM are the cancer types where OR7A10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
PAAD	DFS	Tertile	All	0.068	0.468	<.001	36	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	36	view →
SCLC	DFS	Tertile	All	0.164	0.625	.018	36	view →
SKCM	OS	Tertile	All	0.258	0.781	.020	27	view →
SARC	DFS	Tertile	All	0.105	0.599	<.001	24	view →
PCPG	DFS	Tertile	All	0.535	0.935	.040	9	view →
ESCA	OS	Tertile	III,IV	0.669	0.366	.045	6	view →
COAD	DFS	Tertile	III,IV	1.000	0.395	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR7A10–KICH (DFS)

Open the KICH breakdown →